Taken together, the above studies suggest a relationship between a decrease in Btg2, Egr1, Fos, and Atf3 expression levels and enhanced cardiac hypertrophy in PAH/αKO hearts compared to PAH conditions. The gene discussed is EGR1; the disease is cardiac hypertrophy.